Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative amiodarone timing in elective cardiac surgery patients at risk of atrial fibrillation
IRCT20210424051058N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Atrial fibrillation. Started Jun 2021; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20210424051058N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210424051058N1.